南部非洲控制艾滋病的希望：对疫苗的持续探索。
Hope for HIV control in southern Africa: The continued quest for a vaccine.
作者信息
Bekker Linda-Gail, Gray Glenda E
机构信息
Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.
South African Medical Research Council, Cape Town, South Africa.
出版信息
PLoS Med. 2017 Feb 28;14(2):e1002241. doi: 10.1371/journal.pmed.1002241. eCollection 2017 Feb.
Abstract
In a Perspective, Linda-Gail Bekker and Glenda Gray discuss HIV vaccine development.
摘要
琳达 - 盖尔·贝克尔和格伦达·格雷在一篇《观点》文章中讨论了HIV疫苗的研发情况。
相似文献
1
Hope for HIV control in southern Africa: The continued quest for a vaccine.南部非洲控制艾滋病的希望：对疫苗的持续探索。
PLoS Med. 2017 Feb 28;14(2):e1002241. doi: 10.1371/journal.pmed.1002241. eCollection 2017 Feb.
2
What hope is there for an HIV vaccine?艾滋病疫苗的前景如何？
S Afr Med J. 2004 Oct;94(10):831.
3
Lynn Morris: the continuing quest for an HIV vaccine.林恩·莫里斯：对艾滋病疫苗的持续探索。
Lancet Infect Dis. 2017 Feb;17(2):150. doi: 10.1016/S1473-3099(17)30021-X.
4
[HIV-1 vaccination--is there hope?].[HIV-1疫苗接种——有希望吗？]
Ther Umsch. 2005 Oct;62(10):695-702. doi: 10.1024/0040-5930.62.10.695.
5
Systems biology and the quest for correlates of protection to guide the development of an HIV vaccine.系统生物学与寻找保护相关物以指导 HIV 疫苗研发的探索。
Curr Opin Immunol. 2016 Aug;41:91-97. doi: 10.1016/j.coi.2016.06.010. Epub 2016 Jul 5.
6
Vaccine fundamentals.疫苗基础
Res Initiat Treat Action. 1999 Jan;5(1):8.
7
8
HIV vaccine development: perspective.HIV疫苗研发：展望。
Biotechnol Ther. 1991;2(1-2):205-11.
9
Prospects for a globally effective HIV-1 vaccine.全球有效的HIV-1疫苗的前景。
Vaccine. 2015 Nov 27;33 Suppl 4:D4-12. doi: 10.1016/j.vaccine.2015.03.059. Epub 2015 Jun 20.
10
HIV vaccine trials begin in Oxford.牛津开始进行艾滋病疫苗试验。
BMJ. 2000 Sep 9;321(7261):591.
引用本文的文献
1
Negative vaccine sentiments on South African social media platforms before the COVID-19 pandemic: a mixed methods study.新冠疫情之前南非社交媒体平台上的负面疫苗情绪：一项混合方法研究
Front Health Serv. 2025 May 30;5:1578992. doi: 10.3389/frhs.2025.1578992. eCollection 2025.
2
Major Scientific Hurdles in HIV Vaccine Development: Historical Perspective and Future Directions.艾滋病疫苗研发的主要科学障碍：历史回顾与未来方向。
Front Immunol. 2020 Oct 28;11:590780. doi: 10.3389/fimmu.2020.590780. eCollection 2020.
3
HIV drug resistance in patients in China's national HIV treatment programme who have been on first-line ART for at least 9 months.中国国家艾滋病治疗规划中接受一线抗逆转录病毒治疗至少 9 个月的患者中的 HIV 耐药性。
AIDS Res Ther. 2020 Mar 5;17(1):9. doi: 10.1186/s12981-020-00264-5.
4
Synthesis of an Undecasaccharide Featuring an Oligomannosidic Heptasaccharide and a Bacterial Kdo-lipid A Backbone for Eliciting Neutralizing Antibodies to Mammalian Oligomannose on the HIV-1 Envelope Spike.合成一种具有寡甘露糖七糖和细菌 Kdo-脂 A 骨架的十一聚糖，以诱导针对 HIV-1 包膜刺突上哺乳动物寡甘露糖的中和抗体。
J Am Chem Soc. 2019 May 15;141(19):7946-7954. doi: 10.1021/jacs.9b02872. Epub 2019 Apr 30.
5
HIV Vaccine Preparedness among Men Who Have Sex with Men in Taiwan: Sociocultural and Behavioral Factors.台湾男男性行为者的HIV疫苗接种准备情况：社会文化和行为因素
J Int Assoc Provid AIDS Care. 2019 Jan-Dec;18:2325958219832285. doi: 10.1177/2325958219832285.
6
Setting targets for HIV/AIDS-What lessons can be learned from other disease control programmes?设定艾滋病防治目标：其他疾病控制规划可提供哪些经验教训？
PLoS Med. 2019 Feb 4;16(2):e1002735. doi: 10.1371/journal.pmed.1002735. eCollection 2019 Feb.
7
'Why would you promote something that is less percent safer than a condom?': Perspectives on partially effective HIV prevention technologies among key populations in South Africa.“你为什么要推广一种安全性比避孕套还低的东西呢？”：南非关键人群对部分有效的艾滋病毒预防技术的看法。
SAHARA J. 2018 Dec;15(1):179-186. doi: 10.1080/17290376.2018.1536561.
本文引用的文献
1
Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design.针对HIV的广泛中和抗体及其在疫苗设计中的作用。
Annu Rev Immunol. 2016 May 20;34:635-59. doi: 10.1146/annurev-immunol-041015-055515.
2
Potential future impact of a partially effective HIV vaccine in a southern African setting.一种部分有效的HIV疫苗在南部非洲环境中的潜在未来影响。
PLoS One. 2014 Sep 10;9(9):e107214. doi: 10.1371/journal.pone.0107214. eCollection 2014.
3
Ending AIDS--is an HIV vaccine necessary?终结艾滋病——HIV疫苗是必要的吗？
N Engl J Med. 2014 Feb 6;370(6):495-8. doi: 10.1056/NEJMp1313771.
4
Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand.在泰国使用ALVAC和AIDSVAX疫苗预防HIV-1感染。
N Engl J Med. 2009 Dec 3;361(23):2209-20. doi: 10.1056/NEJMoa0908492. Epub 2009 Oct 20.
5
Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand.泰国曼谷注射吸毒者中一种二价重组糖蛋白120 HIV-1疫苗的随机、双盲、安慰剂对照疗效试验。
J Infect Dis. 2006 Dec 15;194(12):1661-71. doi: 10.1086/508748. Epub 2006 Nov 3.
6
Safety and immunogenicity of an HIV subtype B and E prime-boost vaccine combination in HIV-negative Thai adults.一种B型和E型HIV初免-加强疫苗组合在泰国HIV阴性成年人中的安全性和免疫原性。
J Infect Dis. 2004 Aug 15;190(4):702-6. doi: 10.1086/422258. Epub 2004 Jul 20.
Zotero 插件